BioSyent, Inc. (BIOYF)
10.68
-0.04
(-0.39%)
USD |
OTCM |
Apr 02, 16:00
BioSyent EPS Diluted (Quarterly) : 0.1268 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | -0.01 |
| Aurinia Pharmaceuticals, Inc. | 1.526 |
| Edesa Biotech, Inc. | -0.2819 |
| Lexaria Bioscience Corp. | -0.0746 |
| Xenon Pharmaceuticals, Inc. | -1.314 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.428M |
| Revenue (Quarterly) | 6.936M |
| Total Expenses (Quarterly) | 5.508M |
| Enterprise Value | 102.50M |
| Gross Profit Margin (Quarterly) | 74.65% |
| Profit Margin (Quarterly) | 20.59% |
| Earnings Yield | 5.29% |
| Operating Earnings Yield | 6.65% |
| Normalized Earnings Yield | 5.295 |